Ossiam Seagen Inc. Transaction History

Ossiam

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$191.51 - $216.16 $131,375 - $148,285	-686 Reduced 2.15%	31,155 $6.61 Million
Q2 2023 Aug 11, 2023	BUY	$187.64 - $206.25 $5.78 Million - $6.36 Million	30,823 Added 3027.8%	31,841 $6.13 Million
Q1 2023 May 12, 2023	SELL	$127.59 - $203.08 $338,368 - $538,568	-2,652 Reduced 72.26%	1,018 $206,000
Q4 2022 Feb 13, 2023	BUY	$117.37 - $139.17 $53,990 - $64,018	460 Added 14.33%	3,670 $471,000
Q3 2022 Nov 14, 2022	BUY	$135.27 - $180.11 $434,216 - $578,153	3,210 New	3,210 $439,000
Q4 2021 Feb 14, 2022	SELL	$142.57 - $190.86 $263,469 - $352,709	-1,848 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$135.08 - $161.1 $249,627 - $297,712	1,848 New	1,848 $283,000
Q1 2021 May 17, 2021	SELL	$137.51 - $190.8 $58,441 - $81,090	-425 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$164.63 - $211.93 $69,967 - $90,070	425 New	425 $74,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Ossiam, based on Form 13F filings with the SEC.

Stay updated on Ossiam with notifications on news.